Neuroleptic classification: implications for tardive dyskinesia.
D000661:Amphetamine / Q000008:administration & dosage; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000145:classification*; D001712:Biperiden / Q000008:administration & dosage; D004347:Drug Interactions; D004361:Drug Tolerance; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects* / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D001712:Biperiden; D000661:Amphetamine